Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Julian Hilfiker"'
Autor:
Jan Stetka, Nouraiz Ahmed, Christian Beisel, Damien Luque Paz, Nils Hansen, Julian Hilfiker, Dominik Wolf, Steffen Koschmieder, Florian Geier, Hui Hao-Shen, Milena Kalmer, Stefan Dirnhofer, Tim H. Brümmendorf, Tata Nageswara Rao, Lucia Kubovcakova, Timm Schroeder, Max Endele, Margareta Rybarikova, Radek C. Skoda
Publikováno v:
Blood
Blood, 137 (16)
Blood, 137 (16)
We studied a subset of hematopoietic stem cells (HSCs) that are defined by elevated expression of CD41 (CD41hi) and showed bias for differentiation toward megakaryocytes (Mks). Mouse models of myeloproliferative neoplasms (MPNs) expressing JAK2-V617F
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::622010d9de59c7bbdfe5a74c85004689
https://europepmc.org/articles/PMC8103999/
https://europepmc.org/articles/PMC8103999/
Autor:
Sarah Dimeloe, Max Gassmann, Vladan P. Čokić, Florian Geier, Julien Delezie, Julia Magdalena Majewska, Teresa Cassel, Jonel Trebicka, Thomas Radimerski, Deniz Gezer, Christoph Handschin, Nils Hansen, Radek C. Skoda, Shivam Rai, Danijela Lekovic, Dominik Wolf, Ronny Nienhold, Hui Hao-Shen, Nicolaus Kröger, Serena Di Palma, Steffen Koschmieder, Serena Galli, Andrew N. Lane, Stefan Dirnhofer, Christian Beisel, Julian Hilfiker, Teresa W.-M. Fan, Christoph Hess, Nicola Andina, Tata Nageswara Rao
Publikováno v:
Blood, 134 (21)
Blood
Rao, T N, Hansen, N, Hilfiker, J, Rai, S, Majewska, J M, Leković, D, Gezer, D, Andina, N, Galli, S, Cassel, T, Geier, F, Delezie, J, Nienhold, R, Hao-Shen, H, Beisel, C, Di Palma, S, Dimeloe, S, Trebicka, J, Wolf, D, Gassmann, M, Fan, T W M, Lane, A N, Handschin, C, Dirnhofer, S, Kröger, N, Hess, C, Radimerski, T, Koschmieder, S, Čokić, V P & Skoda, R C 2019, ' JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms ', Blood, vol. 134, no. 21, pp. 1832-1846 . https://doi.org/10.1182/blood.2019000162
Blood
Rao, T N, Hansen, N, Hilfiker, J, Rai, S, Majewska, J M, Leković, D, Gezer, D, Andina, N, Galli, S, Cassel, T, Geier, F, Delezie, J, Nienhold, R, Hao-Shen, H, Beisel, C, Di Palma, S, Dimeloe, S, Trebicka, J, Wolf, D, Gassmann, M, Fan, T W M, Lane, A N, Handschin, C, Dirnhofer, S, Kröger, N, Hess, C, Radimerski, T, Koschmieder, S, Čokić, V P & Skoda, R C 2019, ' JAK2-mutant hematopoietic cells display metabolic alterations that can be targeted to treat myeloproliferative neoplasms ', Blood, vol. 134, no. 21, pp. 1832-1846 . https://doi.org/10.1182/blood.2019000162
Increased energy requirement and metabolic reprogramming are hallmarks of cancer cells. We show that metabolic alterations in hematopoietic cells are fundamental to the pathogenesis of mutant JAK2-driven myeloproliferative neoplasms (MPNs). We found
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4047e0fcbabe5128de1eaedb1f014e6c
https://hdl.handle.net/20.500.11850/382118
https://hdl.handle.net/20.500.11850/382118